| Canadian Nuclear Safety Commission
| news releases
CNSC renews Cameco Corporation’s nuclear fuel facility licence for its Blind River Refinery for a 10-year period. This licence renewal authorizes the production of uranium trioxide from uranium ore concentrates.
| Canadian Nuclear Safety Commission
| news releases
CNSC renews Cameco’s nuclear fuel facility licence for Cameco Fuel Manufacturing Inc. for a 1-year period. This licence renewal authorizes the company to continue manufacturing uranium dioxide fuel pellets and nuclear fuel bundles.
| Canadian Nuclear Safety Commission
| news releases
The Commission has amended Orano Canada Inc.’s uranium mine and mill licence for its McClean Lake Operation, to allow expansion of the JEB Tailings Management Facility.
On November 15, Rumina Velshi, CNSC President and CEO, delivered a keynote address at the G4SR-3 Summit. During her keynote, President Velshi spoke about our readiness to regulate small modular reactors and other new technologies. Nuclear security, regulatory efficiency, engagement and international collaboration are all key to ensuring this readiness. Executive Vice-President Ramzi Jammal also highlighted our modern regulatory framework and the importance of international cooperation efforts in advancing regulatory harmonization.
| Canadian Nuclear Safety Commission
| news releases
The Canadian Nuclear Safety Commission announced its decision to amend Ontario Power Generation’s Darlington operating licence to authorize the production of Molybdenum-99.
| Canadian Nuclear Safety Commission
| media advisories
The Canadian Nuclear Safety Commission (CNSC) would like to inform the media about the upcoming public Commission hearing on NB Power’s licence renewal application for its Point Lepreau Nuclear Generating Station on November 10, 2021.
| Canadian Nuclear Safety Commission
| news releases
The Canadian Nuclear Safety Commission announced its decision to issue BWXT Medical Ltd. a Class IB nuclear substance processing facility licence to operate a nuclear medicine production facility in Ottawa, Ontario.